Cigna: This Dividend Grower Could Be Worth Buying Now

Group 1 - The article promotes a free 2-week trial for iREIT® on Alpha, which offers in-depth research on various investment vehicles including REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, Builders, and Asset Managers [1][2] - Subscribers will gain access to a Ratings Tracker that provides buy/sell recommendations on all covered stocks, along with unlimited access to a multi-year archive of articles [1]